Envista (NYSE:NVST) Lowered to Buy Rating by Wall Street Zen

Key Points

• Envista (NYSE:NVST) was downgraded from a "strong-buy" to a "buy" rating by Wall Street Zen in a recent research note.
• As of now, the stock has an average rating of "Hold" and an average target price of $20.92 according to MarketBeat data.
• Envista reported a 7.7% increase in revenue year-over-year and exceeded earnings expectations with $0.26 EPS for the last quarter.

Wall Street Zen lowered shares of Envista (NYSE:NVST - Free Report) from a strong-buy rating to a buy rating in a research note published on Saturday morning.

NVST has been the topic of a number of other reports. Baird R W raised Envista from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, May 27th. Wells Fargo & Company upped their price target on Envista from $17.00 to $19.00 and gave the company an "equal weight" rating in a report on Friday, August 1st. Evercore ISI increased their price objective on Envista from $19.00 to $23.00 and gave the company an "outperform" rating in a research report on Wednesday, July 9th. Piper Sandler lifted their price objective on Envista from $17.00 to $19.00 and gave the stock a "neutral" rating in a report on Friday, August 1st. Finally, Morgan Stanley upped their target price on shares of Envista from $16.00 to $17.00 and gave the company an "equal weight" rating in a research note on Friday, August 1st. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $20.92.

Envista Trading Up 2.3%

Shares of NYSE NVST traded up $0.47 during midday trading on Friday, hitting $20.77. 2,587,665 shares of the company traded hands, compared to its average volume of 1,580,674. Envista has a 12-month low of $14.22 and a 12-month high of $23.00. The firm has a market cap of $3.45 billion, a P/E ratio of 64.89, a P/E/G ratio of 1.09 and a beta of 0.99. The stock has a 50-day moving average price of $20.41 and a 200 day moving average price of $18.59. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.08 and a current ratio of 2.44.

Envista (NYSE:NVST - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.24 by $0.02. The business had revenue of $682.10 million during the quarter, compared to analyst estimates of $638.21 million. Envista had a net margin of 2.11% and a return on equity of 4.84%. Envista's quarterly revenue was up 7.7% compared to the same quarter last year. During the same period last year, the business posted $0.11 earnings per share. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. As a group, analysts expect that Envista will post 1 earnings per share for the current year.

Institutional Investors Weigh In On Envista

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NVST. Captrust Financial Advisors boosted its position in shares of Envista by 38.4% during the second quarter. Captrust Financial Advisors now owns 15,465 shares of the company's stock worth $302,000 after acquiring an additional 4,290 shares during the last quarter. Tidal Investments LLC raised its stake in shares of Envista by 8.6% in the second quarter. Tidal Investments LLC now owns 40,104 shares of the company's stock valued at $784,000 after acquiring an additional 3,159 shares during the period. Man Group plc lifted its stake in Envista by 62.1% in the second quarter. Man Group plc now owns 59,596 shares of the company's stock worth $1,165,000 after purchasing an additional 22,840 shares during the last quarter. HRT Financial LP bought a new stake in shares of Envista during the 2nd quarter worth approximately $1,809,000. Finally, Holocene Advisors LP purchased a new stake in shares of Envista during the second quarter valued at $43,936,000.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.